Licensed pharmaceutical wholesaler and exporter in India New Delhi · Mumbai[email protected]
Oncology

Rituximab

Rituximab is a prescription medicine. Pharmacotherapeutic group: antineoplastic agents, monoclonal antibodies and antibody drug conjugates (ATC code L01FA01). Bio Bridge Pharma supplies it from India to hospitals, licensed importers, distributors and tender buyers outside India.

  • Prescription medicine
  • Cold chain, 2 to 8 °C
  • Named patient supply where allowed

Presentations we supply

  • Injection 100 mg/10 ml
  • Injection 500 mg/50 ml

Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.

Send Enquiry for Rituximab

Reference information

Summarised from the product information for MabThera. Always follow the product information approved in your own country.

Active substance
Rituximab
Pharmacotherapeutic group
Antineoplastic agents, monoclonal antibodies and antibody drug conjugates (ATC code L01FA01)
Authorised uses
  • Follicular lymphoma
  • Diffuse large B-cell non-Hodgkin's lymphoma
  • Chronic lymphocytic leukaemia
  • Severe active rheumatoid arthritis
  • Granulomatosis with polyangiitis and microscopic polyangiitis
  • Pemphigus vulgaris
Storage (unopened)
Store in a refrigerator (2 °C to 8 °C). Do not freeze. Keep the vial in the outer carton to protect it from light.

Supply from Bio Bridge Pharma

  • The registration route and import licence are confirmed for your destination before we make an offer.
  • Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
  • Cold-chain shipment for this refrigerated product.
  • Named patient supply where the destination country's rules allow it.

Sources

  1. Product information for MabThera: www.ema.europa.eu
Enquiries

Need a medicine supplied outside India?

Send the product, strength and destination country. We confirm the registration route and import licence for that destination, then send our offer.

Send Enquiry